Quest Diagnostics (DGX) PT Raised to $245 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Derik de Bruin raised the price target on Quest Diagnostics (NYSE: DGX) to $245.00 (from $225.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
